Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04635787 · ClinicalTrials.gov registry record
Vital Sensor Monitors for CV19 Detection
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 324
- Enrollment target
NCT04635787: Completed study, sponsored by Northwestern University.
NCT04635787 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 324 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04635787 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 324 participants
- Enrollment target
Study Summary
This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential COVID-19 infections.
Primary Outcome
Device data measuring cough count. Captured by analysis of peak acclerometer graphing and duration in meters per second squared (m/s2).
Interventions
- DEVICE ANNE One
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2021-08-31 |
What the finished NCT04635787 record still lists
NCT04635787 is an observational study that tracks outcomes without assigning an intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ANNE One is the first listed.
NCT04635787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04635787 about?
NCT04635787 is a clinical study titled "Vital Sensor Monitors for CV19 Detection". This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential COVID-19 infections.
What is the current status of trial NCT04635787?
This trial is currently completed. The enrollment target is 324 participants. The study started on 2020-11-05. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT04635787?
The interventions under investigation include: ANNE One (DEVICE).
Who is sponsoring clinical trial NCT04635787?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI